For example, these hybrid nanoparticles‐based ALKBH5 mRNA, which correlates with N6‐methyladenosine modification and affects tumor progression, largely inhibited tumorigenesis and prolonged the survival of preclinical tumor models by restricting glycolysis [127]. The gene discussed is ALKBH5; the disease is neoplasm.